Filing Details
- Accession Number:
- 0001127602-25-006253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-21 16:41:25
- Reporting Period:
- 2025-02-20
- Filing Date:
- 2025-02-21
- Accepted Time:
- 2025-02-21 16:41:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1141722 | C James Foster | C/O Charles River Laboratories 251 Ballardvale Street Wilmington MA 01887 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-20 | 6,075 | $165.01 | 183,639 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,048 | Indirect | 2022 GRAT |
| Common Stock | 9,793 | Indirect | 2023 GRAT |
| Common Stock | 20,000 | Indirect | 2024 GRAT |
| Common Stock | 20,000 | Indirect | 2025 GRAT |
| Common Stock | 230 | Indirect | by Trust |
| Common Stock | 750 | Indirect | By Trust |
| Common Stock | 2,250 | Indirect | By Trust |
| Common Stock | 10,000 | Indirect | Held By Spouse |
Footnotes
- On February 20, 2025, 20,000 shares were transferred from Direct Holdings to the 2025 GRAT account.
Billionaire Hedge Funds
